MediciNova, Inc. (TYO:4875)

MediciNova Statistics

Total Valuation

MediciNova has a market cap or net worth of JPY 11.12 billion. The enterprise value is 6.18 billion.

Market Cap	11.12B
Enterprise Value	6.18B

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	49.15M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.98%
Owned by Institutions (%)	10.98%
Float	42.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	291.31
PB Ratio	1.71
P/TBV Ratio	2.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.48
EV / Sales	156.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.29

Financial Position

The company has a current ratio of 9.86, with a Debt / Equity ratio of 0.01.

Current Ratio	9.86
Quick Ratio	9.76
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.26% and return on invested capital (ROIC) is -16.76%.

Return on Equity (ROE)	-24.26%
Return on Assets (ROA)	-15.82%
Return on Invested Capital (ROIC)	-16.76%
Return on Capital Employed (ROCE)	-30.23%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.94M
Profits Per Employee	-136.72M
Employee Count	13
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, MediciNova has paid 819,415 in taxes.

Income Tax	819,415
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-13.86%
50-Day Moving Average	246.74
200-Day Moving Average	211.54
Relative Strength Index (RSI)	50.24
Average Volume (20 Days)	103,255

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Income Statement

In the last 12 months, MediciNova had revenue of JPY 38.17 million and -1.78 billion in losses. Loss per share was -36.24.

Revenue	38.17M
Gross Profit	3.89M
Operating Income	-1.98B
Pretax Income	-1.78B
Net Income	-1.78B
EBITDA	-1.98B
EBIT	-1.98B
Loss Per Share	-36.24

Balance Sheet

The company has 4.82 billion in cash and 37.76 million in debt, with a net cash position of 4.78 billion.

Cash & Cash Equivalents	4.82B
Total Debt	37.76M
Net Cash	4.78B
Net Cash Per Share	n/a
Equity (Book Value)	6.51B
Book Value Per Share	132.66
Working Capital	4.38B

Cash Flow

In the last 12 months, operating cash flow was -1.44 billion and capital expenditures -428,724, giving a free cash flow of -1.44 billion.

Operating Cash Flow	-1.44B
Capital Expenditures	-428,724
Free Cash Flow	-1.44B
FCF Per Share	n/a

Margins

Gross Margin	10.20%
Operating Margin	-5,185.49%
Pretax Margin	-4,654.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MediciNova does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-15.99%
FCF Yield	-12.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 26, 2006. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 26, 2006
Split Type	Reverse
Split Ratio	0.1

Scores

MediciNova has an Altman Z-Score of 0.04 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.04
Piotroski F-Score	1